Clinical Trials Browser

Phase 3 × Neoplasms × Classical hematology × Clear all

NCT07410117 2026-05-27

ROXI-CAT-I

Phase 3 Recruiting

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07493304 2026-03-25

ROXI-CAT-II

Phase 3 Not yet recruiting

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism

NCT06940570 2025-10-23

MATCH

Phase 3 Suspended

Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT05029063 2025-07-09

TRIM-Line

Phase 3 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism

NCT03837171 2024-06-25

TRANSPORT

Phase 3 Completed

Classical hematology

Anemia, Neoplasms, Shock, Septic

NCT05704894 2023-01-30

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Phase 3 Unknown

Classical hematology

Anemia, Neoplasms

NCT00858364 2022-11-30

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Phase 3 Terminated

2,549 enrolled 19 charts

Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

NCT04999176 2021-08-10

VALERIA

Phase 3 Unknown

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02583191 2021-05-03

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Phase 3 Terminated

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Phase 3 Completed

841 enrolled 24 charts

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Phase 3 Completed

1,046 enrolled 24 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT03003273 2019-02-01

DALFEN

Phase 3 Terminated

Classical hematology

Neoplasms, Febrile Neutropenia

NCT02746185 2018-08-13

CASTA-DIVA

Phase 3 Completed

Classical hematology

Neoplasms, Venous Thromboembolism

NCT00236951 2018-02-20

Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

Phase 3 Completed

224 enrolled 9 charts

Classical hematology

Anemia, Neoplasms

NCT00911170 2017-12-29

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Phase 3 Completed

847 enrolled 21 charts

Classical hematologyGastrointestinal

Colonic Neoplasms, Fever, Neoplasms, Neutropenia, Rectal Neoplasms, Colorectal Neoplasms, Febrile Neutropenia

NCT01164046 2014-12-03

Longheva

Phase 3 Terminated

Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00091858 2013-05-08

Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer

Phase 3 Completed

Classical hematology

Anemia, Neoplasms

NCT00694382 2013-01-23

SAVE-ONCO

Phase 3 Completed

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01206907 2012-08-17

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

Phase 3 Withdrawn

Classical hematology

Anemia, Sickle Cell, Arthritis, Juvenile, Neoplasms, Chronic Pain

NCT01343680 2012-05-30

Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients

Phase 3 Terminated

Classical hematology

Anemia, Aplastic, Metabolic Diseases, Neoplasms

NCT00210587 2011-06-10

An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation

Phase 3 Completed

Classical hematology

Anemia, Neoplasms

NCT00210730 2011-06-10

The Duration Study

Phase 3 Terminated

Classical hematology

Anemia, Neoplasms

NCT00341055 2011-06-10

A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.

Phase 3 Completed

Classical hematology

Anemia, Neoplasms

NCT00261677 2011-05-23

A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy

Phase 3 Completed

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00350090 2011-05-19

A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.

Phase 3 Terminated

Classical hematology

Anemia, Neoplasms

NCT00270101 2011-05-18

The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

Phase 3 Completed

Classical hematologyPlasma cell

Anemia, Multiple Myeloma, Neoplasms

NCT00270127 2011-05-18

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

Phase 3 Completed

Classical hematology

Anemia, Neoplasms

NCT00270166 2011-05-18

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Phase 3 Completed

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicLymphoidPlasma cellThoracic

Anemia, Breast Neoplasms, Esophageal Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00083434 2011-04-27

Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy

Phase 3 Terminated

Classical hematology

Anemia, Neoplasms

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Phase 3 Completed

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00628043 2009-09-18

Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Phase 3 Completed

Classical hematology

Anemia, Neoplasms

NCT00115167 2009-05-11

A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study

Phase 3 Completed

Classical hematology

Anemia, Neoplasms

NCT00038064 2008-09-15

Anemia in Patients With a Non-Myeloid Malignancy

Phase 3 Completed

Classical hematology

Anemia, Neoplasms

NCT00111137 2008-02-28

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

Phase 3 Completed

Classical hematology

Anemia, Neoplasms

NCT00145652 2007-07-30

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Phase 3 Completed

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00037791 2006-11-09

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Phase 3 Completed

Classical hematologyLymphoidPlasma cell

Lymphoma, Multiple Myeloma, Neoplasms, Thrombocytopenia